Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Longeveron Inc. Class A Common Stock
LGVN | US
1.12
USD-0.04
-3.45%
LGVN | US
Loading StockChartView...
About Longeveron Inc. Class A Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
13/04/2026
Close
1.12
Open
1.14
High
1.17
Low
1.07
Longeveron Inc. a clinical stage biotechnology company develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B an allogeneic medicinal signaling cell therapy product isolated from the bone marrow of young healthy adult donors. It is conducting Phase 1 Phase 2a and Phase 2b clinical trials in various indications such as aging-related frailty alzheimer's disease metabolic syndrome acute respiratory distress syndrome and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami Florida.
View LessLGVN | US
Risk
109.8
Sharpe
-0.20
Luna's Score
60/100
Recommendation
Hold
Luna says (LGVN | US)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
84.4%1 month
109.8%3 months
164.3%6 months
126.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.13
Debt to equity
0.12
Debt to assets
0.09
Ent. to EBITDA
-49.61
Ent. to rev.
17.17
PEG
-
Other Fundamentals
EBITDA
-17.22M
MarketCap
16.08M
MarketCap(USD)
16.08M
Div. yield
-
Op. margin
-747.86
Erngs. growth
-
Rev. growth
115.70
Ret. on equity
-142.16
Short ratio
1.60
Short perc.
6.01
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.35
Range1M
0.41
Range3M
0.76
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.32
Price X volume
907.72K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -49.61 | 0.53 | Cheaper |
| Ent. to Revenue | 17.17 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.13 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 164.28 | 72.80 | Riskier |
| Debt to Equity | 0.12 | -1.23 | Expensive |
| Debt to Assets | 0.09 | 0.25 | Cheaper |
| Market Cap | 16.08M | 3.66B | Emerging |
